Fresenius Medical Care AG & Co. KGaA (XETRA:FME) - Share price - Overview

Stock Report

Fresenius Medical Care AG & Co. KGaA FME

Last Price
81.31

Day Change
1.50|1.88%

As of 24/04/2017
17:35:17 CEST | EUR
Minimum 15 Minutes Delay.

Last Close79.81
Day Range80.08 - 81.45
Mkt Cap24.90Bil
52-Wk Range70.00 - 85.65
Yield %1.00
ISINDE0005785802
Volume839,597
P/E-
P/S1.46
P/CF12.47

Share Price

Financials
201420152016
More ...
Income Statement
Revenue15,831.6116,737.5817,910.79
Operating Income2,254.532,326.732,637.52
Net Income1,045.271,029.451,243.27
Basic EPS3.463.384.07
Avg. Diluted Shares Outstanding303305306
Balance Sheet
Current Assets6,724.716,984.577,313.96
Non Current Assets18,722.3918,548.9119,619.99
Total Assets25,447.1025,533.4926,933.94
Current Liabilities3,477.294,185.855,037.30
Total Liabilities16,003.7915,646.3416,125.22
Total Equity9,443.319,887.1410,808.72
Cash Flow
Operating Cash Flow1,861.391,960.052,139.88
Capital Expenditure-931.63-952.94-1,029.99
Free Cash Flow929.771,007.101,109.89

In millions, except "Basic EPS". Currency is USD.

Company Profile

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company, which is operating in both the field of dialysis products and dialysis services.

Sector

Healthcare

Industry

Medical Care

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

109,319
Key Stats
More ...
Price/Earning TTM-
Price/Book2.42
Price/Sales TTM-
Rev Growth (3 year avg)7.03
EPS Growth (3 year avg)-
Operating Margin % TTM14.73
Net Margin % TTM6.94
ROE TTM12.01
Debt/Equity0.67
Dividends
PreviousLatest
More ...
Declared Date19/01/1628/03/17
Ex-Div13/05/1612/05/17
Paid13/05/1616/05/17
Amnt0.800.96
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.